Dermata Therapeutics, Inc.
DRMA
$1.15
-$0.03-2.54%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.14M | 4.95M | 4.73M | 7.44M | 6.63M |
| Total Receivables | -- | -- | -- | 8.40K | 100.00 |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 525.60K | 145.20K | 353.20K | 440.90K | 615.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 18.00K | 144.30K | 92.90K | 91.20K | 76.20K |
| Total Current Assets | 6.69M | 5.24M | 5.18M | 7.98M | 7.32M |
|
|
|||||
| Total Current Assets | 6.69M | 5.24M | 5.18M | 7.98M | 7.32M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 6.69M | 5.24M | 5.18M | 7.98M | 7.32M |
|
|
|||||
| Total Accounts Payable | 863.60K | 1.33M | 822.50K | 866.00K | 474.50K |
| Total Accrued Expenses | 1.08M | 591.20K | 549.20K | 757.60K | 442.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.95M | 1.92M | 1.37M | 1.62M | 916.80K |
|
|
|||||
| Total Current Liabilities | 1.95M | 1.92M | 1.37M | 1.62M | 916.80K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.95M | 1.92M | 1.37M | 1.62M | 916.80K |
|
|
|||||
| Common Stock & APIC | 67.27M | 62.67M | 60.33M | 59.74M | 57.66M |
| Retained Earnings | -62.52M | -59.35M | -56.52M | -53.39M | -51.25M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.74M | 3.32M | 3.81M | 6.36M | 6.41M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.74M | 3.32M | 3.81M | 6.36M | 6.41M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.74M | 3.32M | 3.81M | 6.36M | 6.41M |
|
|
|||||
